Literature DB >> 9574856

Which patients receive antidepressants? A 'real world' telephone study.

M Bouhassira1, M P Allicar, C Blachier, A Nouveau, F Rouillon.   

Abstract

INTRODUCTION: The use of antidepressants has been questioned with respect to both undertreatment and inadequate prescription. The present investigation was therefore launched to assess the psychopathology profiles of antidepressant users.
METHODS: A representative sample was constituted on the basis of usual antidepressant consumption, and ICD 10 compatible diagnoses were obtained after telephone administration of a structured psychiatric interview.
RESULTS: The most often used drugs were fluoxetine, followed by tricyclic antidepressants. Coprescription existed in slightly less than two thirds of antidepressant users. ICD 10 diagnoses were compared to currently available prescription guidelines. Fluoxetine prescription, as compared to other drugs, was found to be significantly more compliant with these guidelines; conversely, in 22% of antidepressant users, no complete ICD 10 diagnosis could be documented. These results are discussed in the light of report accuracy and anecdotal or 'heterodox' indications of antidepressants.
CONCLUSION: Altogether, the present study confirms previous doubts regarding appropriate use of antidepressants and stresses the need for more explicit and comprehensive clinical guidelines. It does not substantiate, however, any evidence for a 'recreational' use of these products.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574856     DOI: 10.1016/s0165-0327(97)00193-6

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study.

Authors:  Kang Sim; N B Lee; Hong C Chua; Rathi Mahendran; Senta Fujii; Shu-Yu Yang; Mian-Yoon Chong; Tianmei Si; Yan L He; Min S Lee; Kil M Sung; Eun K Chung; Yiong H Chan; Naotaka Shinfuku; Chay H Tan; Norman Sartorius; Ross J Baldessarini
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

Review 2.  Tianeptine: a review of its use in depressive disorders.

Authors:  A J Wagstaff; D Ormrod; C M Spencer
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Identifying physician-recognized depression from administrative data: consequences for quality measurement.

Authors:  Claire M Spettell; Terry C Wall; Jeroan Allison; Jaimee Calhoun; Richard Kobylinski; Rachel Fargason; Catarina I Kiefe
Journal:  Health Serv Res       Date:  2003-08       Impact factor: 3.402

4.  Antidepressants plus benzodiazepines for adults with major depression.

Authors:  Yusuke Ogawa; Nozomi Takeshima; Yu Hayasaka; Aran Tajika; Norio Watanabe; David Streiner; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2019-06-03

5.  Antidepressant use in black and white populations in the United States.

Authors:  Hector M González; Thomas Croghan; Brady West; David Williams; Randolph Nesse; Wassim Tarraf; Robert Taylor; Ladson Hinton; Harold Neighbors; James Jackson
Journal:  Psychiatr Serv       Date:  2008-10       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.